28 May, EOD - Indian

SENSEX 81312.32 (-0.29)

Nifty 50 24752.45 (-0.30)

Nifty Bank 55417 (0.12)

Nifty IT 37465.75 (-0.10)

Nifty Midcap 100 57141.4 (-0.02)

Nifty Next 50 66996.2 (-0.29)

Nifty Pharma 21393.3 (-0.61)

Nifty Smallcap 100 17784 (0.33)

28 May, EOD - Global

NIKKEI 225 37722.4 (0.00)

HANG SENG 23258.31 (-0.53)

S&P 5937.5 (-0.15)

LOGIN HERE

companylogoIndo Borax & Chemicals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 524342 | NSE Symbol : INDOBORAX | ISIN : INE803D01021 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
07-May-2025 13-May-2025 Final Dividend Indo Borax & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the Fourth Quarter and Financial Year ended March 31 2025. and recommend dividend if any subject to approval of shareholders in the ensuing Annual General Meeting of the Company for the financial year ended March 31 2025 Board Meeting Outcome for Outcome Of The Board Meeting (As Per BSE Announcement Dated on: 13/05/2025)
03-Feb-2025 11-Feb-2025 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited Standalone and Consolidated financial statements for the quarter and nine months ended 31st December 2024. Pursuant to the provision of the Regulation 30 (read with Para A of Schedule III) and 33 of the SEBI (LODR) Regulations, 2015 Board has considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2024. (As Per BSE Announcement Dated on: 11/02/2025)
02-Dec-2024 09-Dec-2024 Delisting of Shares INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2024 inter alia to consider and approve A meeting of Board of Directors of the Company will be held on 9th December 2024 to consider voluntary delisting of Equity Shares of the Company from The Calcutta Stock Exchange Limited Pursuant to provision of Regulation 30 of the SEBI (LODR) Regulations, 2015 please find herewith the outcome of the Board Meeting held on 9th December 2024 (As per BSE Announcement Dated on 09/12/2024)
05-Nov-2024 13-Nov-2024 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2024 Outcome of the Board Meeting held on 13th November, 2024 (As Per BSE Announcement Dated on: 13/11/2024)
05-Aug-2024 12-Aug-2024 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended 30th June 2024 and any other business with the permission of Chair. The Board of Directors of the Company at its meeting held on today, i.e. 12th August, 2024 have interalia approved the Standalone and Consolidated unaudited financial results for the quarter ended 30th June, 2024 (As Per BSE Announcement Dated on: 12/08/2024)
15-May-2024 25-May-2024 Accounts INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve financial results for the year ended 31st March 2024 and to consider and recommend dividend if any for the financial year 2023-24 Outcome of the Board Meeting (As Per BSE Announcement Dated on 25/05/2024)
19-Mar-2024 26-Mar-2024 Others INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2024 ,inter alia, to consider and approve Reconstitution of various committees of Board of Directors Outcome of the Board Meeting held on 26th March, 2024 (As per BSE Announcement Dated on 26/03/2024)
01-Feb-2024 13-Feb-2024 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve unaudited financial results of the company for he quarter and nine months ended 31st December 2023 and to transact any other businesses that may be deem necessary with the permission of the Chair Pursuant to the Provision of the Regulation 30 and 33 of the SEBI LODR, Regulations, 2015 Please find attached financial results for the quarter ended 31st December, 2023 Outcome of the Board Meeting held on 13th February, 2024 (As Per BSE Announcement Dated on 13/02/2024)
31-Oct-2023 09-Nov-2023 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter and half year ended 30th September 2023.
02-Aug-2023 12-Aug-2023 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2023 The Board of Directors of the Company at its meeting held on August 12, 2023 at registered office of the company, have inter-alia transacted/approved the Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter Ended June 30, 2023 pursuant to the Provisions of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The aforesaid unaudited financial results of the Company as approved by the Board and Limited Review Report thereto, issued by the Statutory Auditors of the Company, are being submitted herewith for taking on your record. (As Per BSE Announcement Dated on 12.08.2023)
04-May-2023 13-May-2023 Accounts INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 inter alia to consider and approve 1. The annual financial results of the Company for the financial year ended 31st March 2023; 2. To consider and recommend dividend if any on equity shares of the Company for the financial year 2022-23. Further as per the Companys Code of Conduct to regulate monitor and report trading by designed persons the trading window for dealing in securities of the company is closed from April 1 2023 for all designated persons and will end 48 hours after the aforesaid financial results are made public on 13th May 2023. 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2023 along with the Auditors Report thereon. 2. A dividend of Rs. 1/- ( @ 100%) per equity shares of Rs. 1/- each for the financial year ended 31st March, 2023, subject to approval of the shareholders at the ensuing Annual General Meeting. 3. The board, on recommendation of the Nomination and Remuneration Committee, has subject to the approval of the members and such other approvals as may be required, approved the re-appointment of Mr. Sajal Jain, as Managing Director and Chief Financial Officer of the Company for a further period of five (5) years w. e. f. 27th May, 2023 as the present term expires on 26th May, 2023. You are requested to take the above information on record Pursuant to the provision of the Regulation 30 and 33 of the SEBI (LODR) Regulation, 2015, as amended, we wish to inform you that the Board of Directors of the Company at its Meeting held today on Saturday, 13th May, 2023 has approved the following: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2023 along with the Auditors Report thereon. 2. A dividend of Rs. 1/- ( @ 100%) per equity shares of Rs. 1/- each for the financial year ended 31st March, 2023, subject to approval of the shareholders at the ensuing Annual General Meeting. 3. The board, on recommendation of the Nomination and Remuneration Committee, has subject to the approval of the members and such other approvals as may be required, approved the re-appointment of Mr. Sajal Jain, as Managing Director and Chief Financial Officer of the Company for a further period of five (5) years w. e. f. 27th May, 2023 as the present term expires on 26th May, 2023. (As Per BSE Announcement Dated on 13.05.2023)
01-Feb-2023 10-Feb-2023 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Pursuant to regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 10th February 2023 inter alia to consider approve and take on record the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31st December 2022 along with Limited Review Report thereon. Further as per the Companys Code of Conduct for prohibition of insider trading the trading window for dealing in securities of the Company by all designated persons and their immediate relatives is closed from 1st January 2023 and will end 48 hours after the results are made public on 10th February 2023 The Board of Directors of the Company at its meeting held on February 10, 2023 at registered office of the company, have inter-alia transacted/approved the Standalone and Consolidated Unaudited Financial Results of the Company for the 3rd Quarter/Nine Months Ended December 31, 2022 pursuant to the Provisions of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The aforesaid unaudited financial results of the Company as approved by the Board and Limited Review Report thereto, issued by the Statutory Auditors of the Company, are being submitted herewith for taking on your record (As per BSE Announcement Dated on 10/02/2023) Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements), Regulation, 2015, please find enclosed copies of Unaudited Financial Results for the quarter and nine months ended 31st December, 2022 published in the following newspapers on 11th February, 2023. 1. Free Press Journal 2. Navshakti Kindly take note of the same. (As Per BSE Announcement Dated on 11.02.2023)
01-Nov-2022 08-Nov-2022 Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022 inter alia to consider and approve the unaudited financial results of the Company for the quarter and six months ended 30th September 2022. Further as per the Companys Code of Conduct for prohibition of insider trading the trading window for dealing in securities of the Company is closed from 1st October 2022 and will end 48 hours after the results are made public on 8th November 2022 Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements), Regulation, 2015, please find enclosed copies of Unaudited Financial Results for the quarter/half year ended 30th September, 2022 published in the following newspapers on 9th November, 2022. 1. Free Press Journal 2. Navshakti (As Per BSE Announcement Dated on 09/11/2022)
22-Jul-2022 28-Jul-2022 Quarterly Results Quarterly Results INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended 30th June, 2022. Further, as per the Company's Code of Conduct for prohibition of insider trading, the trading window for dealing in securities of the Company is closed from 1st July, 2022 and will end 48 hours after the results are made public on 28th July, 2022. You are requested to take the above information on record. In terms of the provision of Regulation 30 (read with Part A of Schedule III) and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose the statement of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2022, which were approved and taken on record by the Board of Directors at its Meeting held today i.e. on 28th July, 2022. (As Per BSE Announcement dated on 28.07.2022)
21-May-2022 28-May-2022 Accounts INDO BORAX & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve 1. The annual financial results of the Company for the financial year ended 31st March 2022; 2. To consider and recommend dividend if any on equity shares of the Company for the financial year 2021-22 Further as per the Companys Code of Conduct to regulate monitor and report trading by designed persons the trading window for dealing in securities of the company is closed from April 1 2022 for all designated persons and will end 48 hours after the aforesaid financial results are made public on 28th May 2022. You are requested to take the above information on record. Indo Borax & Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2022, inter alia, has approved the following: - A dividend of Rs. 1/- (Rupees One only) per equity shares of Rs. 1 /- each for the financial year ended March 31, 2022, subject to approval of the shareholders at the ensuing Annual General Meeting. Pursuant to the provision of the Regulation 30 (read with Para A of Schedule III) and 33 of the SEBI (LODR ) Regulation, 2015, as amended, we wish to inform you that the Board of Directors of the Company at its Meeting held today on Saturday, 28th May, 2022 has approved the following: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2022 along with the Auditors Report thereon. 2. A dividend of Rs. 1/- (Rupees One only) per equity shares of Rs. 1/- each for the financial year ended 31st March, 2022, subject to approval of the shareholders at the ensuing Annual General Meeting. Further, we enclose the following: i. Statement of Audited Financial Results -Standalone and Consolidated for the quarter and year ended 31st March, 2022 along with Auditor's Reports thereon. ii. Declaration in terms of Regulation 33(3) (d) of SEBI (LODR) Regulation, 2015. (As Per BSE Announcement Dated 28.05.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +